Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery.

IF 3 4区 医学 Q2 PHARMACOLOGY & PHARMACY Current drug targets Pub Date : 2024-01-01 DOI:10.2174/0113894501284598240226102943
Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur
{"title":"Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery.","authors":"Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur","doi":"10.2174/0113894501284598240226102943","DOIUrl":null,"url":null,"abstract":"<p><p>Total Parenteral Nutrition (TPN) is a method of providing nutrients directly into the bloodstream for individuals who are unable to meet their nutritional needs through the normal digestive process or gastrointestinal system. It provides macronutrients and micronutrients in a single container, reducing handling and contamination risks and making it more cost-effective. TPN has the potential to be used as a drug delivery system, with applications in combination therapies, personalized medicine, and integrating advanced technologies. It can enhance drug dosage precision and provide nutritional assistance, potentially reducing hospitalization and improving patient outcomes. However, implementing new applications requires thorough testing and regulatory approval. TPN could be particularly useful in pediatric and geriatric care and could also contribute to global health by combating malnutrition in areas with limited medical resources. Healthcare professionals prepare a sterile solution tailored to each patient's nutritional needs, and administration involves a central venous catheter. However, the simultaneous administration of medications with PN admixtures can result in pharmacological incompatibility, which can impact the stability of the oil-in-water system. The European Society for Clinical Nutrition and Metabolism and the American Society for Parenteral and Enteral Nutrition recommendations advise against including non-nutrient drugs in PN admixtures due to safety concerns. This review focuses on the utilization of Total Parenteral Nutrition (TPN) as a method for delivering drugs. It discusses the benefits and difficulties associated with its commercial application and offers suggestions for future research endeavors.</p>","PeriodicalId":10805,"journal":{"name":"Current drug targets","volume":" ","pages":"306-329"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113894501284598240226102943","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Total Parenteral Nutrition (TPN) is a method of providing nutrients directly into the bloodstream for individuals who are unable to meet their nutritional needs through the normal digestive process or gastrointestinal system. It provides macronutrients and micronutrients in a single container, reducing handling and contamination risks and making it more cost-effective. TPN has the potential to be used as a drug delivery system, with applications in combination therapies, personalized medicine, and integrating advanced technologies. It can enhance drug dosage precision and provide nutritional assistance, potentially reducing hospitalization and improving patient outcomes. However, implementing new applications requires thorough testing and regulatory approval. TPN could be particularly useful in pediatric and geriatric care and could also contribute to global health by combating malnutrition in areas with limited medical resources. Healthcare professionals prepare a sterile solution tailored to each patient's nutritional needs, and administration involves a central venous catheter. However, the simultaneous administration of medications with PN admixtures can result in pharmacological incompatibility, which can impact the stability of the oil-in-water system. The European Society for Clinical Nutrition and Metabolism and the American Society for Parenteral and Enteral Nutrition recommendations advise against including non-nutrient drugs in PN admixtures due to safety concerns. This review focuses on the utilization of Total Parenteral Nutrition (TPN) as a method for delivering drugs. It discusses the benefits and difficulties associated with its commercial application and offers suggestions for future research endeavors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
将全胃肠外营养(TPN)用作给药载体。
全胃肠外营养(TPN)是一种将营养物质直接输入血液的方法,适用于无法通过正常消化过程或肠胃系统满足营养需求的患者。它在一个容器中提供宏量营养素和微量营养素,减少了处理和污染风险,使其更具成本效益。TPN 具有作为给药系统的潜力,可应用于综合疗法、个性化医疗和先进技术的集成。它可以提高药物剂量的精确性并提供营养帮助,从而有可能减少住院时间并改善患者的治疗效果。然而,新应用的实施需要全面的测试和监管审批。TPN 在儿科和老年病护理方面尤其有用,还能在医疗资源有限的地区消除营养不良现象,为全球健康做出贡献。医护人员根据每位病人的营养需求配制无菌溶液,并通过中心静脉导管给药。然而,在使用 PN 混合物的同时给药可能会导致药理不相容,从而影响水包油系统的稳定性。出于安全考虑,欧洲临床营养与代谢学会和美国肠外与肠内营养学会建议不要在 PN 混合物中加入非营养药物。本综述重点讨论了将全肠外营养(TPN)作为一种给药方法的使用情况。它讨论了与商业应用相关的益处和困难,并对未来的研究工作提出了建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current drug targets
Current drug targets 医学-药学
CiteScore
6.20
自引率
0.00%
发文量
127
审稿时长
3-8 weeks
期刊介绍: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
期刊最新文献
Assessing Anti-Acne Potentials Via in-vitro, Ex-vivo, and in-vivo Models: A Comprehensive Approach. From Structure to Function: Isatin Derivatives as a Promising Class of Antiviral Agents. MT1JP: A Pivotal Tumor-Suppressing LncRNA and its Role in Cancer Progression and Therapeutic Potential. New Advances in Drug Research for Myopia Control in Adolescents. Emerging Combinatorial Drug Delivery Strategies for Breast Cancer: A Comprehensive Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1